- Home
- MRVL vs ABT Comparison
MRVL vs ABT Comparison
Compare MRVL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRVL | ABT |
|---|---|---|
| Founded | 1995 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.9B | 152.9B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MRVL | ABT |
|---|---|---|
| Price | $298.20 | $88.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 32 | 20 |
| Target Price | $120.28 | ★ $130.90 |
| AVG Volume (30 Days) | ★ 49.1M | 8.8M |
| Earning Date | 05-28-2026 | 04-16-2026 |
| Dividend Yield | 0.15% | ★ 2.76% |
| EPS Growth | ★ 400.98 | N/A |
| EPS | 0.04 | ★ 0.61 |
| Revenue | $8,194,600,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $35.14 | $10.75 |
| Revenue Next Year | N/A | $8.10 |
| P/E Ratio | $7,307.50 | ★ $144.87 |
| Revenue Growth | ★ 42.09 | 5.67 |
| 52 Week Low | $61.44 | $81.97 |
| 52 Week High | $324.20 | $137.49 |
Technical Indicators
Market Signals| Indicator | MRVL | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 62.70 | 47.26 |
| Support Level | $76.86 | $84.96 |
| Resistance Level | $324.20 | $89.34 |
| Average True Range (ATR) | 30.28 | 2.03 |
| MACD | 0.44 | 0.33 |
| Stochastic Oscillator | 78.01 | 38.35 |
Price Performance
Historical ComparisonAbout MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.